Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...

Acute Pancreatitis I: Introduction

Acute Pancreatitis I: Introduction

Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:

Chronic Pancreatitis I: Introduction

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Characterisation of the Novel HLA-C*03:02:18 Allele by Sequencing-Based Typing in a Taiwanese Individual.

HLA·2026

Same author

Reduction of Blood Culture Contamination Through an Evidence-Based, Multidisciplinary Quality Improvement Initiative.

Journal for healthcare quality : official publication of the National Association for Healthcare Quality·2026

Same author

New Tuberculosis Infection and Reactivation of Tuberculosis in Patients with Psoriasis or Psoriatic Arthritis Receiving IL-23 Inhibitors: A Systematic Literature Review.

Dermatology and therapy·2026

Same author

High Serum IgE is Associated with Risk of Severe Exacerbations Among Non-Eosinophilic Bronchiectasis.

Lung·2026

Same author

Association between neonatal sepsis and lung function in school-age children born preterm.

Pediatric research·2026

Same author

Persistence and Long-Term Disease Control of Interleukin-17 Inhibitors and Interleukin-23 Inhibitors in Patients with Psoriasis: A Nationwide Cohort Study in Japan.

Psoriasis (Auckland, N.Z.)·2026

Search research articles

Related Experiment Video

Updated: Dec 22, 2025

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Association Between Thionamides and Acute Pancreatitis: A Case-Control Study.

Jia-Yin Guo^1,2, Chia-Ling Chang^3,4, Ching-Chu Chen^2,5

¹Department of Medicine, China Medical University, Taichung, Taiwan.

Thyroid : Official Journal of the American Thyroid Association

|May 9, 2020

Summary

This study found no clear link between thionamide medications, like carbimazole and methimazole, and acute pancreatitis risk in hyperthyroid patients. Further research is needed to confirm these findings for thyroid medication safety.

Keywords:

carbimazole hyperthyroidism methimazole pancreatitis propylthiouracil thionamides

More Related Videos

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Related Experiment Videos

Last Updated: Dec 22, 2025

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

Area of Science:

Endocrinology
Pharmacovigilance
Gastroenterology

Background:

Thionamides are common hyperthyroidism treatments.
Recent studies suggest a potential link between carbimazole/methimazole and pancreatitis.
The risk association between thionamides and pancreatitis requires clarification.

Purpose of the Study:

To investigate the association between thionamide use and acute pancreatitis.
To determine if specific thionamides (carbimazole, methimazole, propylthiouracil) increase pancreatitis risk.

Main Methods:

A population-based case-control study using the Taiwan Longitudinal Health Insurance Database (2000-2013).
9,204 acute pancreatitis cases were matched with 36,816 controls based on age, sex, comorbidities, and cancer.
Multivariate logistic regression and sensitivity analyses were employed to estimate odds ratios (ORs) and 95% confidence intervals (CIs).

Main Results:

No significant difference in thionamide, carbimazole, methimazole, or propylthiouracil use was observed between cases and controls.
Adjusted ORs for acute pancreatitis associated with thionamides were 1.03 (0.86-1.24), carbimazole 0.90 (0.63-1.30), methimazole 1.05 (0.84-1.31), and propylthiouracil 1.00 (0.74-1.34).
Sensitivity analyses yielded consistent results, confirming the main findings.

Conclusions:

This study did not find a statistically significant association between the use of thionamides and the risk of developing acute pancreatitis.
The findings suggest that thionamides, including carbimazole, methimazole, and propylthiouracil, may not be a significant risk factor for acute pancreatitis.